Inflammatory Processes in Drug Discovery

Venue: Park Hyatt at the Bellevue Hotel

Location: Philadelphia, Pennsylvania, United States

Event Date/Time: Sep 22, 2003 End Date/Time: Sep 23, 2003
Report as Spam

Description

PRESENTING:

3M Pharmaceuticals
Abbott Laboratories
AstraZeneca
Astex Technology Ltd.
Atherogenics Inc.
Aventis Pharmaceuticals
Boehringer-Ingelheim Pharmaceuticals
Bristol-Myers Squibb
Celgene San Diego
Merck Research Laboratories
Meyer Pharmaceuticals
Molecular Staging
Pfizer Global R&D Groton Labs
Rigel Inc.
Roche Pharmaceuticals
Vertex Pharmaceuticals
Albert Einstein College of Medicine
University of North Carolina

KEYNOTE SESSIONS:

Cytokine Profiling in Inflammatory Diseases
Dhaval D. Patel, M.D., Ph.D.
Professor, Department of Medicine
Director, Thurston Arthritis Research Center
Chief, Division of Rheumatology, Allergy and Immunology
UNIVERSITY OF NORTH CAROLINA

Using Inflammation Mediators to Quantify Drug Effects During Clinical Trials
Stephen Kingsmore, M.B., Ch.B, B.A.O.
Chief Operating Officer
MOLECULAR STAGING

Bulking up Drug Discovery: The Humanisation Process
Martin Braddock, Ph.D.
Associate Director, Respiratory & Inflammation Research Area
ASTRAZENECA

Venue